Salus Biomed Raises Over RMB 100M in Pre-Series A Financing
Salus Biomed, a sequencing and spatial omics platform provider based in Guangdong, has reportedly raised...
Finance
Kunshi Biotechnology Raises Angel Funding for Engineered Macrophage Platform
China-based Kunshi Biotechnology (Shenzhen) Co., Ltd, a company specializing in gene editing, biomaterials, and synthetic...
Sihuan Pharma to Acquire Additional Stake in Heilongjiang Duoduo Pharma
China-based Sihuan Pharmaceutical Holdings Group Ltd’s subsidiary, Beijing Centergate Technologies (Holding) Co., Ltd (SHE: 000931),...
Ningbo Menovo to Sell Zhejiang Liaoyuan Pharma Stake to Jemincare for RMB 512.58M
China-based Ningbo Menovo Pharmaceutical Co., Ltd (SHA: 603538) has announced plans to transfer all of...
Ausper Biopharma Raises USD 16M for HBV Drug and Vaccine Development
Ausper Biopharma, Inc, a developer of drugs and vaccines for chronic hepatitis B virus (HBV)...
Alioth Biotech Raises RMB 100M in Series A Financing for Pharma Processing Products
China-based Alioth Biotech (Shanghai) Co., Ltd has raised close to RMB 100 million (USD 13.9...
HICOMP MicroTech Raises RMB 100M in Series B+ Financing for Microfluidics Expansion
China-based micro/nano technology developer HICOMP MicroTech (Suzhou) Co., Ltd has raised RMB 100 million (USD...
AlphaLife Sciences Raises Series A+ Funding for Clinical Research SaaS
China-based clinical research SaaS service provider AlphaLife Sciences has reportedly raised “tens of millions” of...
SprintRay Raises Over USD 100M in Series D Financing for Dental 3D Printing
Zhejiang-based SprintRay Co., a one-stop digital chair side solution provider for dental institutions, has reportedly...
VectorBuilder Raises $56.6M in Series C to Expand Life Science R&D
Guangzhou-based VectorBuilder, a genetic engineering specialist incubated by the state-owned Guangzhou Industrial Investment and Capital...
Roche Boosts China Investment with Additional RMB 250 Million
Swiss pharmaceutical giant Roche (SWX: ROG) has pledged to invest an additional RMB 250 million...
Betta Pharmaceuticals Raises $140.5M for Drug Industrialization Base in Zhejiang
China’s Betta Pharmaceuticals Co., Ltd. (SHE: 300558) plans to raise RMB 1 billion ($140.5 million)...
NeuShen Therapeutics Closes $20M Series Pre-A Financing for CNS Drug Development
NeuShen Therapeutics has announced the successful closure of a $20 million Series pre-A financing round...
Gluetacs Therapeutics Files IND for Molecular Glue Degrading Agent in China
Gluetacs Therapeutics has reported filing an Investigational New Drug (IND) application for its first molecular...
Global Cord Blood Corporation Appoints Liquidators Amid Shareholder Dispute
Global Cord Blood Corporation (OTCMKTS: CORBF) has announced that the Grand Court of the Cayman...
Ubrigene Raises Hundreds of Millions in Series C Financing Round
Yiming (Beijing) Cell Biotechnology Co., Ltd, also known as Ubrigene, a gene and cell therapy...
ThunderBio Secures Funding from Guangzhou LBP for PCR Innovation
ThunderBio Innovation Limited, a specialist in droplet microfluidics and molecular diagnostics based in Zhejiang, has...
F-star Therapeutics’ Takeover by Sino Biopharmaceutical Delayed Amid CFIUS Review
UK-based biotech F-star Therapeutics Inc. (NASDAQ: FSTX) announced in a stock exchange press release that...
Shenzhen NeuroPlus Secures Seed Funding for Neuromodulation and Bioelectronic Medicine
Shenzhen NeuroPlus has reportedly raised “tens of millions” of renminbi in a seed financing round...
Kamari Pharma Completes $8M Investment from Chinese Fund GIBF2
Israel-based Kamari Pharma has announced the completion of an $8 million investment from the Chinese...